Head, Global Oncology Pipeline, Medical Affairs
AbbVie
- Location
- Mettawa, IL, United States
- Employment
- Full Time
- Work model
- On-Site
- Level
- Staff
- H-1B history
- 94 approvals (FY2023)
- Posted
- 2h ago
About this role
Company Description
About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description *Hybrid 3x per week in Lake County, IL, Florham Park, NJ or San Francisco, CA. Purpose : Lead global pipeline medical affairs strategy and develop compelling differentiation across the lifecycle, leveraging distinctive insights from the market to shape AbbVie TA pipeline Shape initial value and evidence strategy and initiate Ev Gen plans, leveraging insights from payors, patients, and physicians. Direct pipeline execution team, ensuring pull through of strategy to Enterprise Research MSLs Collaborate with counterparts in International TAs, Global Therapeutic Area BU and Development Represent TA in pipeline governance, where aligned with TA BU Head Interface with Operations and Medical Engagement teams to operationalize pipeline strategy Responsibilities : Lead and oversee pipeline (including BD) medical, value and evidence strategy development across all disease areas within TA to serve both US and International markets for all indications/ brands up to 24-36 months pre-launch (in any geography) Drive compelling differentiation of medical, value and evidence strategy from discovery, leveraging distinctive insights from US and International markets Coordinate across TAs to ensure that TA-level pipeline strategies coalesce into a coherent AbbVie pipeline strategy Ensure HCP, Patients and Payor insights are incorporated into the developments programs to accelerate and differentiate clinical and commercialization strategies (e.g., streamlined patient data collection, patient finding) Co-create the Brand strategy for all assets and ensure US and International market insights are embedded in the brand strategy Represent medical affairs in pipeline-related governance, serving as the single point of contact for commercial and development counterparts Serve as final decision maker (pre-BU head) for all pipeline-related strategy and decisions Manage pipeline resources effectively, redirecting pipeline team to enterprise critical assets along the lifecycle as needed, starting as early as discovery Ensure effective handover to US and International inline/ launch teams, onboarding with relevant TAs to share insights/ approach/ etc. from pipeline strategy efforts and minimizing duplication of effort across pipeline and inline teams Lead cross-functional gap assessment and Integrated Evidence Planning (IEP) and collaborate with Value and Evidence Define strategy for enterprise research MSLs in US and affiliates, leveraging pipeline insights to develop priorities and shape tactical plans Coordinate with pipeline execution group in US Medical Engagement to drive execution Collaborate with US Medical Engagement to track impact-focused KPIs and re-shape pipeline strategy based on impact or best practices Qualifications M.D., or equivalent advanced degree in a relevant scientific discipline (e.g., oncology/hematology) 15+ years of experience in the pharmaceutical or biotechnology industry, with a focus on oncology, specifically hematology Demonstrated expertise in clinical development, regulatory requirements, and commercialization of oncology therapies Proven leadership experience in medical affairs, including managing direct and indirect reports, cross-functional teams and influencing strategic direction at the senior executive level Strong scientific knowledge of solid tumor biology,